{
  "success": true,
  "pagesUsed": [
    1,
    2,
    3,
    6,
    7,
    8,
    9,
    10,
    14,
    15,
    16,
    17,
    18,
    19,
    25,
    26,
    27,
    28,
    29,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Pembrolizumab (MK-3475)",
        "type": {
          "id": "90c94cf5-1603-4c20-8f3c-406d354765c1",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "73d6ff4e-8383-415c-9efe-b4033821a798",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-PD-1 monoclonal antibody for advanced/metastatic esophageal cancer",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Paclitaxel",
        "type": {
          "id": "0e2e6e27-db55-4944-aac8-01e44480e857",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "0b628be3-103d-42d1-8d7c-647b8f01e019",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Docetaxel",
        "type": {
          "id": "eb93a60c-3042-41e2-90ba-2a524052e3da",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "c174490a-c28a-4c60-b4aa-32328e40dca1",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Irinotecan",
        "type": {
          "id": "100abce4-b753-4961-b9c1-5f0f992a52e2",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "66eaf3f0-31d3-4391-acf6-9afe58be629e",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "a50b5cd6-632a-47ce-aa52-644077278af0",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "3b9f5915-86bd-411b-81ae-29d93d606271",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for management of immune-related adverse events and as premedication for chemotherapy"
      },
      {
        "id": "int_6",
        "name": "Antihistamines",
        "type": {
          "id": "c6ee6e6a-36f5-4657-98fc-b467d02a9a12",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "55d515eb-593a-4e40-94c0-511d42abf713",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for infusion reaction management and chemotherapy premedication"
      },
      {
        "id": "int_7",
        "name": "Antineoplastic systemic chemotherapy",
        "type": {
          "id": "bdce6511-420f-4348-9fae-52fd0feb08d8",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "3e8a5efc-745b-429d-9ef5-e2ead6fd4c06",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited during screening and treatment phase unless specified in protocol"
      },
      {
        "id": "int_8",
        "name": "Live vaccines",
        "type": {
          "id": "7266cd45-5e95-4ee9-b8b4-d3d6599dafe4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "3041033c-d106-4b9f-a31a-d3c83975c8c7",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 30 days prior to first dose and during trial for pembrolizumab arm"
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Pembrolizumab",
        "administrableDoseForm": {
          "id": "8340a980-c885-42f1-af53-36d4d0656232",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "08c25884-9b8a-4b96-9bb8-fe52da87d0f5",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "46c0a456-58b8-4386-9cbd-02779c1d7172",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Merck Sharp & Dohme Corp."
      },
      {
        "id": "prod_2",
        "name": "Paclitaxel",
        "administrableDoseForm": {
          "id": "7bd0149c-bcea-4941-8434-51804a4aadde",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "be9444cb-0c2d-4b54-93fc-371c3817d3ac",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "8c6d5e8b-f0f6-4329-b54c-ec3b7f02a4f5",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_3",
        "name": "Docetaxel",
        "administrableDoseForm": {
          "id": "c82be3c1-7b57-43fe-9e28-ee1fafe33b8e",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "df32f39b-4925-46d0-809a-389b08177ad0",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "048919a5-9fcb-4912-840b-a5352eda2c07",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_4",
        "name": "Irinotecan",
        "administrableDoseForm": {
          "id": "ebaf8bcb-1911-44e2-a714-50231907252c",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "b85a2b6d-20de-497a-9640-558caa62c1f2",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "42262052-8adc-42d0-ba20-a157f25d2467",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_4"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Pembrolizumab Regimen",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "Every 3 weeks",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression, unacceptable toxicity, or 35 administrations (approx. 2 years)"
      },
      {
        "id": "admin_2",
        "name": "Paclitaxel Regimen",
        "instanceType": "Administration",
        "dose": "80-100 mg/m2",
        "doseFrequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_3",
        "name": "Docetaxel Regimen",
        "instanceType": "Administration",
        "dose": "75 mg/m2",
        "doseFrequency": "Day 1 of every 21-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_4",
        "name": "Irinotecan Regimen",
        "instanceType": "Administration",
        "dose": "180 mg/m2",
        "doseFrequency": "Day 1 of every 14-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Pembrolizumab",
        "instanceType": "Substance",
        "description": "Humanized monoclonal antibody against PD-1"
      },
      {
        "id": "sub_2",
        "name": "Paclitaxel",
        "instanceType": "Substance",
        "description": "Taxane antineoplastic agent"
      },
      {
        "id": "sub_3",
        "name": "Docetaxel",
        "instanceType": "Substance",
        "description": "Taxane antineoplastic agent"
      },
      {
        "id": "sub_4",
        "name": "Irinotecan",
        "instanceType": "Substance",
        "description": "Topoisomerase I inhibitor"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 8,
      "productCount": 4,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Pembrolizumab (MK-3475)",
        "role": "Investigational Product",
        "description": "Anti-PD-1 monoclonal antibody for advanced/metastatic esophageal cancer"
      },
      {
        "name": "Paclitaxel",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Docetaxel",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Irinotecan",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Corticosteroids",
        "role": "Rescue Medication",
        "description": "Used for management of immune-related adverse events and as premedication for chemotherapy"
      },
      {
        "name": "Antihistamines",
        "role": "Concomitant Medication",
        "description": "Permitted for infusion reaction management and chemotherapy premedication"
      },
      {
        "name": "Antineoplastic systemic chemotherapy",
        "role": "Concomitant Medication",
        "description": "Prohibited during screening and treatment phase unless specified in protocol"
      },
      {
        "name": "Live vaccines",
        "role": "Concomitant Medication",
        "description": "Prohibited within 30 days prior to first dose and during trial for pembrolizumab arm"
      }
    ],
    "products": [
      {
        "name": "Pembrolizumab",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Merck Sharp & Dohme Corp."
      },
      {
        "name": "Paclitaxel",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      },
      {
        "name": "Docetaxel",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      },
      {
        "name": "Irinotecan",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Pembrolizumab",
        "description": "Humanized monoclonal antibody against PD-1"
      },
      {
        "name": "Paclitaxel",
        "description": "Taxane antineoplastic agent"
      },
      {
        "name": "Docetaxel",
        "description": "Taxane antineoplastic agent"
      },
      {
        "name": "Irinotecan",
        "description": "Topoisomerase I inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Pembrolizumab Regimen",
        "dose": "200 mg",
        "frequency": "Every 3 weeks",
        "route": "Intravenous",
        "duration": "Until disease progression, unacceptable toxicity, or 35 administrations (approx. 2 years)"
      },
      {
        "name": "Paclitaxel Regimen",
        "dose": "80-100 mg/m2",
        "frequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Docetaxel Regimen",
        "dose": "75 mg/m2",
        "frequency": "Day 1 of every 21-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Irinotecan Regimen",
        "dose": "180 mg/m2",
        "frequency": "Day 1 of every 14-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "devices": []
  }
}